http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100123096-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6928a4722175b6afaf60db3754437c7 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016 |
filingDate | 2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eb20768acb68ba08ba5b14b176ee78e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35c1e9424c8f885bb96a02b2dd219cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed7aada4a7d6449450ad739c8d848fb7 |
publicationDate | 2010-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20100123096-A |
titleOfInvention | Pharmaceutical composition for treating prostate cancer containing sucrose-based compound as an active ingredient |
abstract | The present invention provides a pharmaceutical composition for treating prostate cancer, which is a novel medicinal use of β-D- (3,4-disphosphafoyl) fuructofurinosyl-α-D- (6-sine apoyl) glucopyranoside compound. It is about.n n n The β-D- (3,4-disphosphafoyl) fuructofurinosyl-α-D- (6-new apoyl) glucopyranoside compound according to the present invention is an androgen and an androgen receptor. By inhibiting the function of prostate cancer and androgen-dependent diseases of the prostate hyperplasia and androgen-related alopecia (alopecia or baldness) can be developed as an anti-androgen drug that functions as a treatment or blocker. |
priorityDate | 2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 194.